Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody. (2022)
Attributed to:
The Role Of Antibody in Enabling Cell-mediated Control of HCMV Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci162282
PubMed Identifier: 36219482
Publication URI: http://europepmc.org/abstract/MED/36219482
Type: Journal Article/Review
Volume: 132
Parent Publication: The Journal of clinical investigation
Issue: 23
ISSN: 0021-9738